Ballentine Partners LLC Reduces Position in Danaher Co. (NYSE:DHR)

Ballentine Partners LLC lessened its holdings in shares of Danaher Co. (NYSE:DHRFree Report) by 24.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,412 shares of the conglomerate’s stock after selling 4,993 shares during the quarter. Ballentine Partners LLC’s holdings in Danaher were worth $3,566,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also modified their holdings of the company. Banco Santander S.A. purchased a new position in shares of Danaher during the 3rd quarter worth $683,000. First Citizens Bank & Trust Co. lifted its stake in shares of Danaher by 0.6% during the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock valued at $6,156,000 after buying an additional 149 shares in the last quarter. Parkside Financial Bank & Trust lifted its stake in shares of Danaher by 4.8% during the 3rd quarter. Parkside Financial Bank & Trust now owns 3,080 shares of the conglomerate’s stock valued at $764,000 after buying an additional 142 shares in the last quarter. Keybank National Association OH lifted its stake in shares of Danaher by 0.5% during the 3rd quarter. Keybank National Association OH now owns 553,155 shares of the conglomerate’s stock valued at $137,238,000 after buying an additional 2,567 shares in the last quarter. Finally, Pallas Capital Advisors LLC lifted its stake in shares of Danaher by 180.5% during the 4th quarter. Pallas Capital Advisors LLC now owns 8,753 shares of the conglomerate’s stock valued at $2,025,000 after buying an additional 5,633 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. KeyCorp lifted their target price on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Barclays downgraded shares of Danaher from an “overweight” rating to an “equal weight” rating and set a $240.00 price target on the stock. in a report on Wednesday, January 24th. The Goldman Sachs Group downgraded shares of Danaher from a “buy” rating to a “neutral” rating and reduced their price target for the company from $215.00 to $205.00 in a report on Thursday, December 7th. Finally, TheStreet upgraded shares of Danaher from a “c+” rating to a “b-” rating in a report on Friday, December 8th. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $266.00.

Read Our Latest Analysis on DHR

Danaher Price Performance

Shares of Danaher stock traded down $1.60 during trading hours on Wednesday, reaching $244.34. The company’s stock had a trading volume of 1,882,059 shares, compared to its average volume of 2,739,073. The firm has a 50 day moving average price of $248.60 and a 200-day moving average price of $230.28. Danaher Co. has a one year low of $182.09 and a one year high of $259.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37. The stock has a market cap of $180.94 billion, a P/E ratio of 38.49, a P/E/G ratio of 3.77 and a beta of 0.83.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.18. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The firm had revenue of $6.41 billion for the quarter, compared to the consensus estimate of $6.10 billion. During the same period in the previous year, the firm posted $2.87 EPS. The business’s quarterly revenue was down 10.2% on a year-over-year basis. On average, analysts predict that Danaher Co. will post 7.62 EPS for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is currently 16.90%.

Insider Buying and Selling

In related news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Walter G. Lohr sold 3,289 shares of the business’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $251.15, for a total transaction of $826,032.35. Following the completion of the sale, the director now directly owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,957 shares of company stock valued at $8,265,802. Company insiders own 11.10% of the company’s stock.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.